Sae Yumita   Sadahisa Ogasawara   Miyuki Nakagawa   Susumu Maruta   Tomomi Okubo   Norio Itokawa   Yotaro Iino   Masamichi Obu   Yuki Haga   Atsuyoshi Seki   Tadayoshi Kogure   Takamasa Ishino   Keita Ogawa   Kisako Fujiwara   Terunao Iwanaga   Naoto Fujita   Takafumi Sakuma   Ryuta Kojima   Hiroaki Kanzaki   Keisuke Koroki   Masanori Inoue   Kazufumi Kobayashi   Soichiro Kiyono   Masato Nakamura   Naoya Kanogawa   Tomoko Saito   Takayuki Kondo   Ryo Nakagawa   Shingo Nakamoto   Ryosuke Muroyama   Tetsuhiro Chiba   Ei Itobayashi   Masanori Atsukawa   Yoshihiro Koma   Ryosaku Azemoto   Kenji Ito   Hideaki Mizumoto   Jun Kato   Naoya Kato   
BMC gastroenterology 23(1) 101-101 2023年3月 [査読有り]
BACKGROUND: Hyperprogressive disease (HPD) is a phenomenon with greatly accelerated tumor growth and clinical deterioration rates compared to pre-therapy, in patients treated with immune checkpoint inhibitors (ICI). The aim of this study is to cla...